You are here: Industry Insights > Financial Report

News List

Financial Report: Roche 1H Results contractpharma
July 23, 2021
Diagnostics Division sales grew 49% due to high demand for COVID-19 tests and strong momentum in routine testing.
Financial Report. Roche contractpharma
February 07, 2021
Newly launched medicines Tecentriq, Hemlibra, Ocrevus, Perjeta and Kadcyla offset the impact of competition from biosimilars for established medicines.
Financial Report. Lilly contractpharma
February 07, 2021
Recognizes worldwide revenue of $871.2 million in the quarter for bamlanivimab COVID-19 treatment.
Financial Report：Merck contractpharma
November 06, 2020
Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.
Financial Report: Amgen contractpharma
November 06, 2020
Revenues up 12% in the quarter to $6.4 billion.
Financial Report; Pfizer contractpharma
November 06, 2020
Revenues down 4% in the quarter to $12.1 billion.
Financial Report: Novartis contractpharma
November 06, 2020
Pharmaceutical sales up 2% driven by Entresto, Cosentyx and Zolgensma.
Financial Report; Abbvie contractpharma
November 02, 2020
Revenue up 52% in the quarter to $12.9 billion.
Financial Report: PPD contractpharma
October 30, 2020
Comments: Clinical Development Services revenue was $1.0 billion in the quarter, up 19% and Laboratory Services revenue was $225.2 million, up 27%.
Financial Report: Gilead contractpharma
October 29, 2020
Comments: HIV Product sales were $4.5 billion, up 8% primarily due to the continued strength of the HIV franchise and Biktarvy share continues to grow in the U.S. HCV Product sales declined 31% to $464 million impacted by delayed patient starts due to ...

Previous page 1 2 3 Next page